Stockscreener 앱 받기
0.00
100.00%
-7.02
전일 마감가:
$7.02
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$562.77M
수익:
$414.29M
순이익/손실:
$-99.81M
주가수익비율:
0.00
EPS:
-1.3348
순현금흐름:
$-28.65M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$7.695
애콜레이드 Stock (ACCD) Company Profile
명칭
Accolade Inc
전화
610-834-2989
주소
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
ACCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
0.00 | 562.77M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
235.71 | 39.16B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
59.91 | 11.21B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
102.39 | 8.50B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.26 | 11.16B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
38.89 | 6.79B | 906.14M | -52.62M | 89.62M | -0.3621 |
애콜레이드 Stock (ACCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 재확인 | Needham | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-17 | 재개 | DA Davidson | Neutral |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-05-24 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2023-03-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-02-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-02-02 | 개시 | Raymond James | Outperform |
| 2022-09-08 | 재개 | Piper Sandler | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-05-02 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-04-29 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-29 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Underweight |
| 2022-04-07 | 개시 | Guggenheim | Neutral |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-05-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-03-11 | 재개 | Goldman | Buy |
| 2021-01-15 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-08 | 개시 | Canaccord Genuity | Buy |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-07-27 | 개시 | BofA Securities | Buy |
| 2020-07-27 | 개시 | Credit Suisse | Neutral |
| 2020-07-27 | 개시 | Goldman | Buy |
| 2020-07-27 | 개시 | Morgan Stanley | Overweight |
| 2020-07-27 | 개시 | Piper Sandler | Overweight |
| 2020-07-27 | 개시 | Robert W. Baird | Outperform |
| 2020-07-27 | 개시 | SVB Leerink | Outperform |
모두보기
애콜레이드 주식(ACCD)의 최신 뉴스
Analyzing Accolade (NASDAQ:ACCD) & Spree Acquisition Corp. 1 (NYSE:SHAP) - Defense World
Raymond James Financial Inc. Takes $120,000 Position in Accolade, Inc. (NASDAQ:ACCD) - Defense World
Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Seth Rollins Reveals The One Accolade He Wants That Has Escaped Him In WWE Career - Wrestling Inc.
Accolade Wines to cut brands following Vinarchy launch - Yahoo
Vinarchy unveiled as Pernod, Accolade close wine deal - Yahoo
Vinarchy: A New Global Wine Company - Business Wire
Press Release Distribution & PR Platform - ACCESS Newswire
Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire
Adventus Singapore Pte. Ltd. bags accolade at SBR National Business Awards 2025 - Singapore Business Review
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Digital health startup Transcarent takes Accolade private in $621 million deal - MSN
MedEthix Inc earns two accolades at Healthcare Asia Pharma Awards 2025 - Healthcare Asia Magazine
Transcarent finalizes merger with Accolade - MobiHealthNews
Telehealth startup completes $621 million acquisition of Seattle's Accolade - The Business Journals
Accolade completes merger with Transcarent, shifts control By Investing.com - Investing.com Canada
Accolade completes merger with Transcarent, shifts control - Investing.com
Transcarent Completes Merger With Accolade - Business Wire
AcCOLADE president Robert Cavanaugh sells $3,845 in stock By Investing.com - Investing.com Canada
Accolade EVP general counsel sells $2,642 in stock - Investing.com Australia
Accolade EVP general counsel sells $2,642 in stock By Investing.com - Investing.com South Africa
AcCOLADE president Robert Cavanaugh sells $3,845 in stock - Investing.com
Accolade’s CFO Stephen Barnes sells shares worth $3,013 By Investing.com - Investing.com South Africa
Accolade’s CFO Stephen Barnes sells shares worth $3,013 - Investing.com
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) - ACCESS Newswire
Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - MSN
Accolade shareholders approve merger with Transcarent By Investing.com - Investing.com India
Accolade Stockholders Approve Merger with Transcarent - TipRanks
Accolade Shareholders Greenlight Merger With Transcarent - MarketScreener
Accolade shareholders approve merger with Transcarent - Investing.com
Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire
GLAZER CAPITAL, LLC Acquires Significant Stake in Accolade Inc - GuruFocus
Accolade president Robert Cavanaugh sells $1,264 in stock By Investing.com - Investing.com Australia
Accolade CFO Stephen H. Barnes sells $991 worth of stock By Investing.com - Investing.com Australia
Accolade CEO Rajeev Singh sells $2,018 in stock By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells $1,264 in stock - Investing.com India
Accolade CEO Rajeev Singh sells $2,018 in stock - Investing.com India
Accolade CFO Stephen H. Barnes sells $991 worth of stock - Investing.com
애콜레이드 (ACCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
1.07%
자본화:
|
볼륨(24시간):